Epitome Therapeutics FlexCo
Biotechnology
Overview
Epitome Therapeutics is an early-stage biotechnology company, focused on developing a next-generation epigenome editing platform to transform the way we understand and treat disease.
Funding and backers
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2025
Founded
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Temprian Therapeutics is an early-stage biotechnology company treating vitiligo through a novel treatment that blocks the autoimmune…
At Healthpath, our mission is to transform the way we understand gut health.
AAVantgarde is a clinical-stage biotechnology company developing next-generation therapies for inherited retinal diseases with high unmet…
Eisbach Bio is a clinical-stage biotechnology company developing next-generation cancer therapies with its proprietary ALLOS platform.
We are an early stage startup developing the first-ever treatment for chronic disability caused by stroke.
About Us BioKier Inc. is an early-stage pharmaceutical company developing new proprietary medical foods and drugs for diabetes and related…